Does high molecular weight-hyaluronic acid prevent hormone-induced preterm labor in rats?
S. Cilaker Micili, O. Tarı, I. Neri, S. Proietti, V. Unfer Department of Histology and Embryology, Faculty of Medicine, Dokuz Eylül University, Izmir, Turkey. serap.cilaker@deu.edu.tr
OBJECTIVE: The aim of our study was to test if oral high hyaluronic acid (HMW-HA) administration was effective in contrasting induced preterm birth (PTB) in female Wistar rats.
MATERIALS AND METHODS: A total of 24 pregnant rats were pretreated with placebo or low (2.5 mg/day)/high dose (5 mg/day) of HMW-HA (day 15) and then induced to delivery with mifepristone plus prostaglandin E2 (PGE2) (3 mg/100 µL + 0.5 mg/animal) on the 19th day of pregnancy. The delivery time was recorded and the messenger RNA (mRNA) levels of pro-inflammatory cytokines [tumor necrosis factor-α (TNF-α), interleukin (IL)1β, IL-6] were detected in the uterine tissues by real-time polymerase chain reaction (real PCR). Immunohistochemistry was performed alongside.
RESULTS: Oral HMW-HA was well absorbed in the body and was able to significantly delay the timing of delivery and decrease mRNA synthesis of pro-inflammatory cytokines.
CONCLUSIONS: HMW-HA, by acting in the management of PTB, may represent a new approach to protecting physiological pregnancy.
Free PDF Download![Creative Commons License](https://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
S. Cilaker Micili, O. Tarı, I. Neri, S. Proietti, V. Unfer
Does high molecular weight-hyaluronic acid prevent hormone-induced preterm labor in rats?
Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 7
Pages: 3022-3032
DOI: 10.26355/eurrev_202304_31936